Pharmacokinetic modeling of serum platinum reveals extent of long-term exposure and associated comorbidities after cisplatin treatment

被引:0
|
作者
Trendowski, Matthew R. [1 ]
El-Charif, Omar [1 ]
Mu, Zepeng [1 ]
Ratain, Mark J. [1 ]
Wheeler, Heather [2 ]
Dinh, Paul C. [3 ]
Feldman, Darren R. [4 ]
Ardeshir-Rouhani-Fard, Shirin [3 ]
Hamilton, Robert J. [5 ]
Vaughn, David J. [6 ]
Fung, Chunkit [7 ]
Mushiroda, Taisei [8 ]
Einhorn, Lawrence H. [3 ]
Travis, Lois B. [3 ]
Dolan, M. Eileen [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Loyola Univ Chicago, Chicago, IL USA
[3] Indiana Univ, Indianapolis, IN 46204 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Univ Penn, Philadelphia, PA 19104 USA
[7] Univ Rochester, Med Ctr, JP Wilmot Canc Inst, Rochester, NY 14642 USA
[8] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
关键词
D O I
10.1158/1538-7445.AM2019-3904
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3904
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Pharmacokinetic (PK) modeling of serum platinum to reveal extent of long-term exposure and associated comorbidities after cisplatin treatment.
    El Charif, Omar
    Mu, Zepeng
    Gamazon, Eric R.
    Dinh, Paul C.
    Ardeshirrouhanifard, Shirin
    Monahan, Patrick O.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] LONG-TERM PHARMACOKINETIC BEHAVIOR OF PLATINUM AFTER CISPLATIN ADMINISTRATION
    GAMELIN, E
    ALLAIN, P
    MAILLART, P
    TURCANT, A
    DELVA, R
    LORTHOLARY, A
    LARRA, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 37 (1-2) : 97 - 102
  • [3] Relationship between persistent neurotoxicity and long-term platinum exposure after treatment with cisplatin
    Brouwers, E. E.
    Huitema, A. D.
    Boogerd, W.
    Beijnen, J. H.
    Schellens, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Comorbidities, But Not Mechanism, Are Associated With Long-term Mortality After Stroke
    Rahman, Salwa
    Spagnolo-Allende, Antonio
    Gurel, Kursat
    Bueno, Pedro
    Kozii, Khrystyna
    Khasiyev, Farid
    Elkind, Mitchell S.
    Marshall, Randolph S.
    Gutierrez, Jose
    STROKE, 2022, 53
  • [5] Long-Term Renal Outcomes after Cisplatin Treatment
    Latcha, Sheron
    Jaimes, Edgar A.
    Patil, Sujata
    Glezerman, Ilya G.
    Mehta, Swati
    Flombaum, Carlos D.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (07): : 1173 - 1179
  • [6] Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors
    Boer, H.
    Proost, J. H.
    Nuver, J.
    Bunskoek, S.
    Gietema, J. Q.
    Geubels, B. M.
    Altena, R.
    Zwart, N.
    Oosting, S. F.
    Vonk, J. M.
    Lefrandt, J. D.
    Uges, D. R. A.
    Meijer, C.
    de Vries, E. G. E.
    Gietema, J. A.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2305 - 2310
  • [7] Long-term platinum retention after treatment with cisplatin-based chemotherapy in testicular cancer survivors (TCSs)
    Hjelle, L.
    Gundersen, P. O. M.
    Oldenburg, J.
    Fossa, S. D.
    Tandstad, T.
    Slordahl, L.
    Brydoy, M.
    Bremnes, R.
    Haugnes, H. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S647 - S647
  • [8] Serum Concentration of Thyroid Hormones Long-Term after Sulfur Mustard Exposure
    Moaiedmohseni, Sakine
    Ghazanfari, Tooba
    Mirsharif, Ensie Sadat
    Askari, Nayere
    Mohammad Hassan, Zuhair
    Naghiza-Deh, Mohammad Mehdi
    Faghihzadeh, Soghrat
    Azizi, Fereidoun
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2019, 48 (05) : 949 - 955
  • [9] Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
    Hjelle, Line V.
    Gundersen, Per O. M.
    Hellesnes, Ragnhild
    Sprauten, Mette
    Brydoy, Marianne
    Tandstad, Torgrim
    Wilsgaard, Tom
    Fossa, Sophie D.
    Oldenburg, Jan
    Bremnes, Roy M.
    Haugnes, Hege S.
    ACTA ONCOLOGICA, 2018, 57 (10) : 1392 - 1400
  • [10] SERUM GONADOTROPINS IN POSTMENOPAUSAL WOMEN AFTER LONG-TERM VERAPAMIL TREATMENT
    HULTHEN, UL
    KATZMAN, PL
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S63 - S64